Gambia vs Luxembourg: Previously treated cases tested for RR-/MDR-TB
Gambia
100.0%
in 2024
Luxembourg
100.0%
in 2024
Gambia rank
1st
Luxembourg rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Gambia
- Luxembourg
How they compare
Gambia currently reports 100.0% against 100.0% in Luxembourg, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2012 it was Luxembourg ahead.
Gambia ranks 1st and Luxembourg ranks 1st of 180 countries.
Luxembourg has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gambia | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 100.0% | 100.0% | Luxembourg |
| 2020s | 89.4% | 95.0% | 5.6% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Gambia or Luxembourg?
- Gambia, at 100.0% against 100.0% in Luxembourg as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Gambia and Luxembourg?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Luxembourg?
- 6 years are reported by both, from 2012 to 2024.
- How do Gambia and Luxembourg rank globally for previously treated cases tested for rr-/mdr-tb?
- Gambia ranks 1st and Luxembourg ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.